Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2024 Jan 4;110(3):1653–1662. doi: 10.1097/JS9.0000000000001018

Will synchronous esophageal and lung resection increase the incidence of anastomotic leaks? A multicenter retrospective study

Yixin Liu a, Jianfeng Zhou a, Yimin Gu a,b, Weipeng Hu a,c, Haonan Lin a,d, Qixin Shang a, Hanlu Zhang a, Yushang Yang a,*, Yong Yuan a,*, Longqi Chen a,*
PMCID: PMC10942245  PMID: 38181122

Abstract

Background:

Reports on combined resection for synchronous lung lesions and esophageal cancer (CRLE) cases are rare and mostly individual cases. Furthermore, the feasibility of CRLE has always been a controversial topic. In the current study, the authors retrospectively analyzed the feasibility of CRLE and established an individualized prediction model for esophageal anastomotic leaks after CRLE by performing a multicenter retrospective study.

Methods:

Patients who underwent esophagectomy between January 2009 and June 2021 were extracted from a four-center prospectively maintained database, and those with CRLE at the same setting were matched in a 1:2 propensity score-matched (PSM) ratio to esophagectomy alone (EA) patients. A nomogram was then established based on the variables involved in multivariate logistic regression analysis. Internal validation of the nomogram was conducted utilizing Bootstrap resampling. Decision and clinical impact curve analysis were computed to assess the practical clinical utility of the nomogram. A prognosis analysis for CRLE and EA patients by Kaplan–Meier curves was conducted.

Results:

Of the 7152 esophagectomies, 216 cases of CRLE were eligible, and 1:2 ratio propensity score-matched EA patients were matched. The incidence of anastomotic leaks following CRLE increased significantly (P=0.035). The results of the multivariate analysis indicated the leaks varied according to the type of lung resection (anatomic>wedge resection, P=0.016) and site of resected lobe (upper>middle/low lobe; P=0.027), and a nomogram was established to predict the occurrence of leaks accurately (area under the curve=0.786). Although no statistically significant difference in overall survival (OS) was observed in the CRLE group (P=0.070), a trend toward lower survival rates was noted. Further analysis revealed that combined upper lobe anatomic resection was significantly associated with reduced OS (P=0.027).

Conclusion:

Our study confirms that CRLE is feasible but comes with a significantly increased risk of anastomotic leaks and a concerning trend of reduced survival, particularly when upper lobe anatomic resections are performed. These findings highlight the need for careful patient selection and surgical planning when considering CRLE.

Keywords: combined resection, esophageal anastomotic leaks, esophageal cancer, lung resection, nomogram

Introduction

Highlights

  • This multicenter retrospective study establishes that combined resection for synchronous lung lesions and esophageal cancer (CRLE) is feasible but comes with an increased risk of anastomotic leaks, particularly when anatomical resection involving upper lobe are performed.

  • While overall survival rates did not significantly differ between CRLE and esophagectomy alone, a trend toward lower survival in the CRLE group was noted, especially when the upper lobe was involved.

  • These findings highlight the need for careful patient selection and surgical planning, and they pave the way for the development of individualized prediction models for postoperative outcomes.

Esophageal cancer is one of the most aggressive malignant tumors, characterized by a notably low overall 5-year survival rate1,2. In the clinical investigations concerning esophageal cancer, the coexistence of pulmonary benign or malignant lesions are frequently observed3–5. Among these, certain pulmonary lesions meet the criteria for surgical intervention, necessitating the consideration between combined resection for synchronous lung lesions and esophageal cancer (CRLE) or staged interventions6,7. However, the safety and feasibility of CRLE, as well as the selection of suitable candidates, have also been a controversial topic8. Previous investigations into CRLE have yielded inconsistent findings, primarily attributable to limited sample sizes and variations in types of lung resections9,10. Therefore, a multicenter large-scale study is urgently needed to investigate the clinical characteristics of CRLE patients and their impact on short-term and long-term outcomes.

As one of the most significant complications following curative surgery for esophageal cancer, esophageal anastomotic leaks extend hospitalization duration, disrupt the timely initiation of postoperative adjuvant therapy, raise perioperative mortality rates, and consequently affect the long-term prognosis11,12. Currently, with advancements in surgical techniques, improved nutritional support, and clearer identification of risk factors, there has been a decline in the incidence and severity of leaks13–15. However, with the current rise in the detection rate of lung nodules and increased demand for CRLE, the potential role of CRLE as a risk factor for leaks warrants further investigation and discussion.

In the current study, we retrospectively analyzed the clinical data of patients who underwent CRLE and esophagectomy alone (EA), and explored their clinical characteristics, treatment outcomes, postoperative complications, prognosis, and established an individualized prediction model for leaks after CRLE based on a multicenter large-scale study.

Method

Participants

This study has been reported in line with the strengthening the reporting of cohort, cross-sectional and case–control studies in surgery (STROCSS) criteria16 (Supplemental Digital Content 1, http://links.lww.com/JS9/B624), and registered with the research registry (https://www.researchregistry.com). The process has been reported in line with the STROCSS criteria (Supplemental Digital Content 1, http://links.lww.com/JS9/B624). Four high volume institutions participated in this multicenter retrospective study. This study retrospectively screened patients undergoing curative esophagectomy at these institutions from January 2009 to June 2021. Patients who underwent synchronous lung resections were enrolled. Inclusion criteria included (1) Patients diagnosed with synchronous primary esophageal cancer and pulmonary lesion of lung origin; (2) Surgical excision was performed for both the esophageal carcinoma and the pulmonary lesion; (3) No distant metastasis was detected. Exclusion criteria included (1) Patients with unresectable cancer involving adjacent structures or distant metastasis; (2) those with concomitant malignancies (excluding lung malignancies); (3) Palliative resection. The relevant Ethics Committee provided approval for this study, and the need for patient consent was waived.

Treatment procedure

To evaluate resectability, baseline clinical examination, routine blood analyses, contrast-enhanced computed tomography (CT), ECG, and respiratory function testing, were standard for all patients. Certain patients underwent external ultrasound of the cervical region and positron emission tomography/computed tomography (PET/CT). Esophagectomy was performed using Ivor Lewis, Sweet, and McKeown procedure, depending on the tumor’s location and the extent of its involvement. Type of lung resection includes wedge resection and anatomic resection (lobectomy and segmentectomy). For patients with no evidence of cervical lymph-node metastasis based on preoperative CT and ultrasound, routine two-field lymph-node dissection is performed, otherwise three-field lymph-node dissection is carried out. Neoadjuvant chemotherapy, including paclitaxel plus cisplatin or 5-fluorouracil plus cisplatin, combined with 45 Gy of concomitant radiotherapy, determined surgical feasibility after 2–4 cycles of treatment through preoperative assessment. In evaluating the surgical quality of esophagectomy procedures, we utilized a video assessment scale that emphasized technical performance and oncological quality, with a specific focus on lymphadenectomy completeness and anatomic landmark exposure. Surgeons provided short video clips highlighting these aspects, facilitating efficient and focused assessment by trained independent assessors (Supplementary Material, Supplemental Digital Content 2, http://links.lww.com/JS9/B625). The assessment scale, along with example videos, is included in the supplementary Materials (Supplemental Digital Content 2, http://links.lww.com/JS9/B625), serving as a comprehensive guide for quality assurance in esophagectomy. We classified tumor stage according to the 8th edition of the TNM staging system of esophageal carcinoma and lung cancer.

Study outcomes and follow-up

Patient demographics, clinical characteristics, pathological information, intraoperative index, postoperative major complications, follow-up data were collected. Postoperative complications subsequent to esophagectomy were categorized in accordance with the Esophagectomy Complications Consensus Group system17. Specifically, pneumonia was diagnosed based on criteria encompassing elevated body temperature, leukocytosis, presence of purulent secretions, and radiological evidence of pulmonary infiltration. Major complications were classified according to the Clavien–Dindo classification (grades I–II or higher)18. Operative mortality was defined as the occurrence of death within 30 days following surgery or during the patient’s hospitalization period. Data of patients who were alive or lost to follow-up were censored at the date of their last follow-up. Follow-up assessments were conducted every 3 months during the first 2 years, and then every 6 months thereafter. The last general follow-up of survivors was performed in May 2023.

Statistical analysis

R programming language (version 3.4.3) and SPSS 25.0 software (IBM) were used for the data analysis. Normally distributed continuous variables were analyzed using Student’s t-test, while non-normally distributed continuous variables were assessed using the Mann–Whitney U test. Categorical variables were compared using the χ2 test or Fisher’s exact test as appropriate. We used a 1:2 propensity score-matched (PSM) design, matching one patient who underwent synchronous esophageal and lung surgery with two patients who had EA. The propensity score was calculated using a logistic regression model including variables such as age; sex; BMI; follow-up duration; smoking status; alcohol abuse; esophageal carcinoma type, neoadjuvant therapy, clinical staging, and tumor location.

Survival analysis was conducted using the Kaplan–Meier method. Comparisons were adjusted with Bonferroni correction in subgroup analysis. Multivariate logistic regression analysis was performed on variables with potential risk factors in CRLE and leaks risk factors demonstrated by previous studies. A nomogram prediction model was established based on these risk factors using R software. The calibration curve was generated using the bootstrap method, and the C-index was calculated. Receiver operating characteristic (ROC) curves were plotted for independent risk factors, and the area under the curve (AUC) was computed to validate the nomogram’s performance. The clinical utility of the anastomotic leaks nomogram was evaluated using decision curve analysis (DCA) and clinical impact curve (CIC) via R software. Statistical significance was set at a two-sided P-value of <0.05.

Results

Patient characteristics

Of the 7152 patients who underwent esophagectomy between February 2009 and June 2021, 216 cases of CRLE were eligible, and 1:2 ratio PSM EA patients were matched (Fig. 1). Patient demographic and basic clinicopathological characteristics are shown in Table 1. After matching, the cohorts were comparable in terms of age, sex, BMI, history of smoking, alcohol abuse, hypertension, diabetes mellitus, and coronary artery disease, tumor location, neoadjuvant therapy, clinical T and N stage, and histologic type. There was no significant difference in the esophagectomy procedure for two cohorts (P=0.112). Of note, left thoracotomy was a more common surgical incision for CRLE than EA (41.7 vs. 10.4%; P<0.001), primarily for the requirement of left lung lesion resection. Surgical approach for the CRLE group is generally influenced by the location of the lung lesion, aiming to facilitate the simultaneous resection of both the lung lesion and esophageal cancer through a single incision. However, in scenarios where patients in the CRLE group exhibit suspicious right recurrent laryngeal nerve lymph-node metastases, yet also have a lung lesion on the left, our protocol dictates opting for a right-sided approach for the esophagectomy, while concurrently addressing the left-sided lung lesion. This clinical strategy results in instance where the surgical approach for esophagectomy does not align with the location of the lung lesion.

Figure 1.

Figure 1

Flow chart of patient selection. PSM, propensity score matching.

Table 1.

Baseline characteristics of patient population.

Patients Cohort, No. (%/SD)
Characteristics EA patients (n=432) CRLE patients (n=216) χ2/t P
Age
 ≤60 183 (42.4) 92 (42.6) — —
 >60 249 (57.6) 124 (57.4) <0.001 0.998
Sex
 Male 388 (89.8) 194 (89.8) — —
 Female 44 (10.2) 22 (10.2) 0 1
 BMI (kg/m2) 20.7 (2.77) 21.0 (2.81) −1.184 0.237
Smoking history
 No 137 (31.7) 72 (33.3) — —
 Yes 295 (68.3) 144 (66.7) 0.107 0.744
Alcohol abuse
 No 141 (32.6) 70 (32.4) — —
 Yes 291 (67.4) 146 (67.6) <0.001 0.994
Hypertension
 No 389 (90.0) 190 (88.0) — —
 Yes 43 (10.0) 26 (12.0) 0.456 0.499
Diabetes mellitus
 No 415 (96.1) 205 (94.9) — —
 Yes 17 (3.9) 11 (5.1) 0.229 0.633
CAD
 No 425 (98.4) 213 (98.6) — —
 Yes 7 (1.6) 3 (1.4) <0.001 0.999
Tumor location
 Upper 32 (7.4) 16 (7.4) — —
 Middle 236 (54.6) 118 (54.6) — —
 Lower 164 (38.0) 82 (38.0) 0 1
Neoadjuvant therapy
 No 378 (87.5) 189 (87.5) — —
 Yes 54 (12.5) 27 (12.5) 0 0.988
cT stage
 T1–T2 174 (40.3) 91 (42.1) — —
 T3–T4 258 (59.7) 125 (57.9) 0.135 0.713
cN stage
 N1–N2 340 (78.7) 170 (78.7) — —
 N3–N4 92 (21.3) 46 (21.3) 0 1
Histologic type
 Adenocarcinoma 22 (5.1) 11 (5.1) — —
 SCC 393 (91.0) 196 (90.7) — —
 Others 17 (3.9) 9 (4.2) 0.02 0.991
Esophagectomy procedure
 Ivor Lewis 284 (65.7) 124 (57.4) — —
 McKeown 104 (24.1) 63 (29.2) — —
 Sweet 44 (10.2) 29 (13.4) 4.379 0.112
Esophagectomy approach
 Right thoracotomy 387 (89.6) 126 (58.3) — —
 Left thoracotomy 45 (10.4) 90 (41.7) 83.379 <0.001
Lung resection approach
 Right incision — 114 (52.7) — —
 Left incision — 102 (47.3) — —
Number of resected LNs 18.2 (8.33) 18.9 (10.1) −0.921 0.388
Complete resection
 R1 2 (0.4) 4 (1.9) — —
 R0 430 (99.6) 212 (98.1) 1.703 0.192

Categorical data are shown as number (%) and continuous data as mean±SD.

CAD, coronary artery disease; CRLE, combined resection for synchronous lung lesions and esophageal cancer; EA, esophagectomy alone; LNs, lymph nodes; SCC, squamous cell carcinoma.

Among patients who underwent CRLE in Table 2, three distinct types of synchronous pulmonary lesions were observed: pneumatoceles (n=105, 48.6%), benign nodules (n=71, 32.8%), and malignant nodules (n=40, 18.5%). The predominant surgical approach was wedge resection, performed in 181 patients (83.8%), and 35 patients underwent anatomic resection (16.2%). Notably, pneumonectomy was not performed in any of the cases. In terms of lesion sites, the left upper lobe and the right upper lobe were the most frequently affected sites, accounting for 31.0 and 26.8% of the cases, respectively.

Table 2.

Characteristics related to lung resection.

Characteristics CRLE patients (n=216)
Lung resection procedure
 Wedge resection 187 (86.5)
 Segmentectomy 16 (7.4)
 Lobectomy 13 (6.0)
Lung lesion location
 Left lower lobe 41 (21.7)
 Left upper lobe 61 (31.0)
 Right lower lobe 35 (16.2)
 Right middle lobe 9 (4.1)
 Right upper lobe 58 (26.8)
Lung lesion type
 Lung cancer 40 (18.5)
 Begin nodule 71 (32.8)
 Pulmonary bulla 105 (48.7)
 Lung cancer size, cm 1.66±0.96
Lung cancer stage
 0 2 (5.0)
 I 28 (70.0)
 II 5 (12.5)
 III 5 (12.5)
Lung cancer histology
 Adenocarcinoma 29 (72.5)
 SCC 7 (17.5)
 Others 4 (10.0)

Categorical data are shown as number (%) and continuous data as mean±SD.

CRLE, combined resection for synchronous lung lesions and esophageal cancer; SCC, squamous cell carcinoma.

Intraoperative and short-term postoperative outcomes

All of the intraoperative characteristics of patients with CRLE or EA were documented in Table 3. The estimated blood loss in the CRLE group was significantly greater than that in EA group (154 vs. 125 ml; P=0.020). Furthermore, the CRLE group had a notably longer operative duration (285 min vs. 247 min; P<0.001), though the difference in the length of the postoperative hospital stay was not statistically significant (12.5 days vs. 14.1 days; P=0.096). In the analysis of short-term postoperative outcomes, complications were subcategorized utilizing the Clavien–Dindo classification. We found a significant increase in the incidence and severity of leaks in the CRLE group (Grade II leaks: 6.0 vs. 2.3%; Grade III or higher leaks: 3.2 vs. 2.1%; P=0.035). Despite this discrepancy, there were no discernable differences in other postoperative complications between EA and CRLE in pneumonia, pleural effusion, respiratory failure, pulmonary embolism, deep vein thrombosis, chylothorax, and recurrent laryngeal nerve paralysis. Additionally, no significant difference was observed in readmission rates to the ICU and 30-day mortality between the two cohorts (6.5 vs. 5.3%, P=0.675; 0.1 vs. 0%, P=0.066).

Table 3.

Intraoperative and postoperative outcomes of patients with CRLE or EA.

Patients Cohort, No. (%/SD)
Characteristics EA patients (n=432) CRLE patients (n=216) P
Blood loss 125 (90.0) 154 (169) 0.020
Operation time 247 (49.8) 285 (49.3) <0.001
Postoperative stay (days) 12.5 (9.36) 14.1 (12.3) 0.096
Pneumonia
 No 363 (84.0) 170 (78.7)
 Grade II 31 (7.2) 17 (7.9)
 Grade III or higher 38 (8.8) 29 (13.4) 0.167
Anastomotic leakage
 No 413 (95.6) 196 (90.7)
 Grade II 10 (2.3) 13 (6.0)
 Grade III or higher 9 (2.1) 7 (3.2) 0.035
Pleural effusion
 No 389 (90.0) 183 (84.7)
 Grade II 11 (2.5) 8 (3.7)
 Grade III or higher 32 (7.4) 25 (11.6) 0.138
Respiratory failure
 No 419 (97.0) 209 (96.8)
 Grade II 4 (0.9) 3 (1.4)
 Grade III or higher 9 (2.1) 4 (1.9) 0.851
Pulmonary embolism
 No 431 (99.8) 213 (98.6)
 Yes 1 (0.2) 3 (1.4) 0.215
Deep vein thrombosis
 No 430 (99.5) 211 (97.7)
 Yes 2 (0.5) 5 (2.3) 0.081
Chylothorax
 No 430 (99.5) 213 (98.6)
 Yes 2 (0.5) 3 (1.4) 0.427
RLNP
 No 417 (96.5) 207 (95.8)
 Yes 15 (3.5) 9 (4.2) 0.825
Readmitted in ICU
 No 409 (94.7) 202 (93.5)
 Yes 23 (5.3) 14 (6.5) 0.675
30-day mortality 0 (0) 3 (0.01) 0.066

Categorical data are shown as number (%) and continuous data as mean±SD.

CRLE, combined resection for synchronous lung lesions and esophageal cancer; EA, esophagectomy alone; RLNP, Recurrent laryngeal nerve paralysis.

Risk factors for anastomotic leaks in CRLE patients

As delineated in Table 3, among 216 patients who underwent CRLE, we observed a significant increase in the incidence of leaks (P=0.035). Factors previously identified as associated with esophageal anastomotic leaks following esophageal cancer curative surgery (including sex, BMI, history of diabetes, receipt of neoadjuvant treatment, and postoperative pneumonia) were considered alongside variables specifically pertinent to CRLE (extent and sites of lung resection). Multivariate logistic regression analysis revealed that the type of lung resection (OR=4.297, 95% CI: 1.306–14.137), the site of lung resection (OR=4.109, 95% CI: 1.177–14.339), and postoperative pneumonia (OR=5.241, 95% CI: 1.845–14.891) emerged as independent risk factors for anastomotic leaks (Table 4).

Table 4.

The influencing factors for anastomotic leaks from logistic regression.

Characteristics β S.E. OR (95% CI) P
Sex
 Female Reference
 Male 1.197 1.242 3.311 (0.290–37.80) 0.335
Neoadjuvant therapy
 No Reference
 Yes 0.086 0.747 1.090 (0.252–4.716) 0.908
BMI 0.107 0.092 1.112 (0.929–1.332) 0.246
Diabetes mellitus
 No Reference
 Yes 1.195 0.897 3.304 (0.569–19.183) 0.183
Lung resection type
 Wedge resection Reference
 Anatomical resection 1.458 0.608 4.297 (1.306–14.137) 0.016
Lung resection site
 Middle or lower lobe Reference
 Upper lobe 1.413 0.638 4.109 (1.177–14.339) 0.027
Pneumonia
 No Reference
 Yes 1.657 0.533 5.241 (1.845–14.891) 0.002

Nomogram to predict the risk of anastomotic leaks for CRLE

Following the logistic regression analysis, we developed a clinical nomogram to estimate the probability of leaks following CRLE, incorporating variables as sex, receipt of neoadjuvant therapy, BMI, diabetes mellitus, postoperative pneumonia, extent and sites of lung resection (Fig. 2). The predictive accuracy of the nomogram was subsequently assessed through methods including ROC analysis, calibration curves, DCA, and CIC.

Figure 2.

Figure 2

Nomogram for predicting postoperative anastomotic leaks. This nomogram includes sex, neoadjuvant treatment, BMI, diabetes mellitus, extent and sites of lung resection, and postoperative pneumonia. To estimate the probability of anastomotic leaks, we initially obtain the score of each predictor and subsequently calculate the probability by adding the scores of each predictor to the total score.

The ROC analysis affirmed the nomogram’s robust discriminative ability, yielding an AUC of 0.786 (95% CI: 0.663–0.915) (Fig. 3A). The calibration plot illustrated that the nomogram’s predicted probabilities were well-calibrated with the ideal state, indicating good calibration of the model (Fig. 3B). Furthermore, the DCA indicated that using the nomogram to predict leaks would be more beneficial than either treating all patients or treating none, when the threshold probability was above 3% (Fig. 3C). The CIC showed that if the risk threshold was above 6.5%, the true positive rate of using the nomogram to predict leaks increases significantly (Fig. 3D).

Figure 3.

Figure 3

The performance of the nomogram. The ROC curve (A) for the nomogram; AUC was 0.786 (95% CI: 0.663–0.915). The calibration curve (B) of the nomogram. The calibration curve depicts the agreement between the predicted and observed outcomes. B=1000 repetitions, boot mean absolute error=0.029, n=216. The decision curve analysis (C) and clinical impact curve (D) for the nomogram.

Overall survival

The average follow-up time for the CRLE and EA population was 45.9 and 68.5 months, respectively. Although no statistical difference in OS rate was found between two groups, a trend toward lower survival rates was observed in the CRLE group (HR 0.80, 95% CI 0.62–1.02; P=0.070) (Fig. 4A). The median survival times for the two groups were 67.23 and 69.93 months, respectively. At 5 years, 54.3% (95% CI: 45.87–62.73) of CRLE and 54.4% (95% CI: 48.91–59.88) of EA patients were alive. There were no significant differences between the CRLE and EA groups in 5-year OS (HR 0.84, 95% CI: 0.63–1.11; P=0.20). In further, the subgroup analysis also revealed that patients with lung cancer had no significantly worse OS than those with other lung lesions (pulmonary bulla or benign pulmonary nodule) after CRLE (P=0.342) (cancer vs. bulla: P=0.494; cancer vs. benign nodule: P=0.592; bulla vs. benign pulmonary nodule: P=0.202) (Supplementary Figure, Supplemental Digital Content 3, http://links.lww.com/JS9/B626).

Figure 4.

Figure 4

Kaplan–Meier survival curve for overall survival (OS). (A) Kaplan–Meier survival curve for OS stratified by CRLE and EA. (B) Kaplan–Meier survival curve for CRLE subgroup OS stratified by combined wedge resection of middle or lower lobe, combined wedge resection of upper lobe, combined anatomic resection of middle or lower lobe and combined anatomic resection of upper lobe.

Of note, in the survival subgroup analysis on CRLE patients, when stratified by resection type (anatomic or wedge resection) and resection sites (upper or middle/lower lobe), there was a demonstrable difference in the survival outcomes (P=0.027). Notably, the patients with combined anatomic resection involving upper lobe exhibited significantly inferior OS compared to other CRLE subtypes (Fig. 4B).

Discussion

Compared to studies focusing exclusively on lung or esophageal curative resections, there is a relatively limited clinical data pertaining to CRLE. In previous investigations related to CRLE, most studies were case reports, with limited retrospective cohort studies conducted, which often involved a relatively small patient sample size (typically fewer than 50 patients) and potential outcome conflicts attributable to variations in pulmonary surgical heterogeneity9,19,20. Therefore, a thorough investigation into the safety and complications of CRLE, as well as the selection of appropriate patients, is still warranted. Here, we conducted a multicenter retrospective study, which, to our knowledge, represents the largest sample size in research focused on CRLE.

Utilizing PSM analysis, we observed a significant increase in the incidence of postoperative anastomotic leaks in the CRLE group (9.3 vs. 4.4%; P=0.035). Therefore, we directed subgroup analysis toward identifying CRLE patients at elevated risk for anastomotic leaks. Our findings revealed a markedly higher incidence of leaks among patients who underwent combined anatomic resection, specifically those who had upper lobe or segment resections.

The occurrence of leaks involves multiple factors, such as BMI, receiving neoadjuvant therapy, history of thoracic or abdominal surgery, surgical technique, postoperative infections, anemia, ischemia of the gastric conduit, and low blood oxygen content21–23. However, the literature lacks studies that specifically focus on anastomotic leaks in CRLE12,24. In our research, multivariable analysis demonstrated that postoperative pulmonary infection, combined lung anatomic resection, and lung resection involving upper lobe were independent risk factors for leaks. Sex, BMI, and history of diabetes mellitus were also potential influencing factors for leaks. In this study, among the 20 patients who developed leaks in the CRLE group, only one was female. The difference in corticosteroid-induced sex hormone levels and the rates of smoking and alcohol abuse between males and females may account for the higher occurrence of anastomotic leaks in males25,26. Obese patients may show a higher leaks rate, possibly attributed to the abundant mesenteric fat tissue, resulting in a larger conduit volume and difficulty in accessing the mediastinum27. Furthermore, the well-established association between diabetes and leaks is attributed to hyperglycemia-induced microvascular damage, leading to reduced healing capacity28. The association between neoadjuvant therapy and leaks remains controversial, which may be attributed to variations in the choice of radiotherapy and chemotherapy protocols, duration, and dosage across different centers29,30. Our study suggests that neoadjuvant therapy may not increase the risk of leaks.

In this study, a total of 15 patients underwent CRLE with anatomic resection of the upper lobe of the lung, among whom seven (46.6%) developed leaks after surgery. In our clinical practice, we have observed that postoperative chest radiography taken on the first day often indicate the presence of lung cavities, with the anastomosis site protruding toward the cavity side of the lung in these patients. After anatomic lung resection, the removal of a specific lung lobe or segment can result in negative pressure changes within the thoracic cavity, leading to physiological adjustments in the surrounding structures31–33. For instance, after upper lobe resection, the remaining middle or lower lobe and diaphragm may undergo upward displacement. This redistribution of structures is a natural adaptation to compensate for the loss of lung tissue and maintain functional integrity within the thoracic cavity. Factors that can increase tension at the anastomotic site may contribute to the risk of gastrointestinal anastomotic leakage21,34. We supposed that during CRLE, the removal of the upper lobe or an anatomic resection created a considerable influential negative pressure, which increased tension at the esophageal anastomosis site and thereby raised the risk of leaks.

Based on the results of logistic regression analysis, we developed a nomogram, including sex, receipt of neoadjuvant therapy, BMI, history of diabetes mellitus, extent and sites of lung resection, and postoperative pneumonia. Thoracic surgeons can utilize our nomogram to estimate the risk of leaks following CRLE. This nomogram primarily comprises preoperative clinical factors, allowing thoracic surgeons to make more effective surgical plans. For patients in the CRLE group deemed at high risk for leaks (such as those requiring upper lobe anatomic lung resection), staged surgery may be considered as a preferable option based on the preoperative nomogram assessment. Additionally, strengthened monitoring and perioperative intervention are recommended for such patients. Close attention should be paid to changes in their condition during the perioperative period, especially to the development of postoperative complications, and effective interventions should be taken when necessary.

In survival analysis, for patients with synchronous localized lung lesion and esophageal cancer, no significant OS difference between two groups, but a trend toward lower survival rates was noted. However, in CRLE, patients underwent upper lobe anatomic lung resection had significantly worse outcomes compared to other CRLE patients. This may be attributed to the significant increase in leaks rate in this subset of patients after surgery. Similar to our findings, Markar et al.35 investigated the outcomes of nearly 2500 esophagectomy cases and demonstrated a negative impact of leaks on cancer prognosis (HR 1.28; P=0.022). Additionally, Fransen et al.36 conducted an analysis showing that the severity (P=0.025) and incidence (P=0.043) of leaks following minimally invasive esophagectomy compromised long-term survival in patients with esophageal cancer.

This study aimed to explore the suitable population for CRLE and is the first to investigate the association between CRLE and leaks. In order to minimize confounding bias and enhance the homogeneity of the study population, we conducted PSM analysis. This study is the first to investigated the lung surgical factors associated with leaks in CRLE and constructed nomogram to predict the risk of leaks in such surgeries. However, there are several limitations to the current research. Firstly, this study was limited by its retrospective and observational nature, which may introduce inherent flaws in the data analysis. Secondly, given the potential for differential expertise bias, only surgeons with long-term (>5 years) and recent experience in both procedures were appropriate for CRLE, but expertise bias still existed considering the complexity of the operation. Thirdly, dynamic changes in the anastomosis with respiration were not recorded using EUS to verify the impact of pressure fluctuations in the perianastomotic false lumen, as mentioned above. Thus, there is a need for further randomized controlled clinical trials and animal models to validate these findings and hypotheses.

Conclusion

CRLE indeed elevated the incidence of postoperative anastomotic leaks. Extent of lung resection and the resected site were significantly associated with the risk of anastomotic leaks, particularly in cases of combined anatomic resection involving upper lobe. This approach to combined resection could also potentially undermine long-term survival outcomes, while the different types of pulmonary lesions appeared to have no prognostic impact. Therefore, the risk of CRLE may be acceptable. However, in CRLE cases involving combined anatomic resection of the upper lobe, which show a significantly high incidence of leaks and limited survival benefits, staged surgery might be a more suitable option.

Ethical approval

The Ethics Committee of West China Hospital of Sichuan University (No. 2023486) provided approval for this study.

Consent

The Ethics Committee of West China Hospital of Sichuan University (No. 2023486) provided approval for this study, and the need for patient consent was waived.

Sources of funding

This work was funded by the National Nature Science Foundation of China (82000514), 1•3•5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University (2018HXFH020), Regional Innovation and Collaboration projects of Sichuan Provincial Department of Science and Technology (2021YFQ0026), and National Natural Science Foundation Regional Innovation and Development (U20A20394).

Author contribution

Y.L.: share co–first authorship, concept and design and statistical analysis; J.Z.: share co–first authorship, acquisition, analysis, or interpretation of data, and statistical analysis; Y.G. and H.L.: acquisition, analysis, or interpretation of data; W.H.: acquisition, analysis, or interpretation of data, and critical revision of the manuscript for important intellectual content; Q.S.: acquisition, analysis, or interpretation of data, and supervision; H.Z.: critical revision of the manuscript for important intellectual content; Y.Y.: conceptualization, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis; Y.Y.: critical revision of the manuscript for important intellectual content; L.C.: concept and design, obtained funding, and supervision.

Conflicts of interest disclosure

The authors declare no conflicts of interest.

Research registration unique identifying number (UIN)

Registered at http://www.researchregistry.com and unique identifying number or registration ID: researchregistry 9383.

Guarantor

Yu-Shang Yang and Long-Qi Chen.

Provenance and peer review

Not commissioned, externally peer-reviewed.

Presentation

None.

Data availability statement

The data that support the findings of this study are available from the corresponding author and author initials, upon reasonable request.

Supplementary Material

SUPPLEMENTARY MATERIAL
js9-110-1653-s001.docx (31.2KB, docx)
Download video file (77.1MB, mp4)
js9-110-1653-s003.docx (139.2KB, docx)

Acknowledgements

Assistance with the study: None.

Footnotes

Yixin Liu, Jianfeng Zhou, Yimin Gu, and Weipeng Hu have contributed equally to this work and share first authorship.

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, www.lww.com/international-journal-of-surgery.

Published online 4 January 2024

Contributor Information

Yixin Liu, Email: yixinliu11@163.com.

Jianfeng Zhou, Email: 1152638080@qq.com.

Yimin Gu, Email: yimin_gu@aliyun.com.

Weipeng Hu, Email: dr_weipenghu@163.com.

Haonan Lin, Email: linhn24@163.com.

Qixin Shang, Email: 450763473@qq.com.

Hanlu Zhang, Email: 1125286848@qq.com.

Yushang Yang, Email: dryangysh@scu.edu.cn.

Yong Yuan, Email: yongyuan@scu.edu.cn.

Longqi Chen, Email: drchenlq@scu.edu.cn.

References

  • 1. Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet (London, England) 2013;381:400–412. [DOI] [PubMed] [Google Scholar]
  • 2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–249. [DOI] [PubMed] [Google Scholar]
  • 3. Madani A, Spicer J, Alcindor T, et al. Clinical significance of incidental pulmonary nodules in esophageal cancer patients. J Gastrointest Surg 2014;18:226–232. [DOI] [PubMed] [Google Scholar]
  • 4. van Westreenen HL, Westerterp M, Jager PL, et al. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 2005;46:1321–1325. [PubMed] [Google Scholar]
  • 5. Xue L, Li W, Fan X, et al. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing. Theranostics 2020;10:10606–10618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Munden RF, Erasmus JJ, Wahba H, et al. Follow-up of small (4 mm or less) incidentally detected nodules by computed tomography in oncology patients: a retrospective review. J Thorac Oncol 2010;5:1958–1962. [DOI] [PubMed] [Google Scholar]
  • 7. Dellaportas D, Laliotis A, Zylstra J, et al. Clinical significance of pulmonary nodules in decision-making and management of patients diagnosed with esophageal cancer. Dis Esophagus 2020;33:1–4. [DOI] [PubMed] [Google Scholar]
  • 8. Papaconstantinou D, Tsilimigras DI, Moris D, et al. Synchronous resection of esophageal cancer and other organ malignancies: a systematic review. World J Gastroenterol 2019;25:3438–3449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Zhao H, Misariu AM, Ramirez-GarciaLuna JL, et al. Synchronous esophageal and lung cancers-is combined anatomic resection appropriate? Ann Thorac Surg 2022;113:1354–1360. [DOI] [PubMed] [Google Scholar]
  • 10. Fékété F, Sauvanet A, Kaisserian G, et al. Associated primary esophageal and lung carcinoma: a study of 39 patients. Ann Thorac Surg 1994;58:837–842. [DOI] [PubMed] [Google Scholar]
  • 11. Su’a BU, Mikaere HL, Rahiri JL, et al. Systematic review of the role of biomarkers in diagnosing anastomotic leakage following colorectal surgery. Br J Surg 2017;104:503–512. [DOI] [PubMed] [Google Scholar]
  • 12. van Kooten RT, Voeten DM, Steyerberg EW, et al. Patient-related prognostic factors for anastomotic leakage, major complications, and short-term mortality following esophagectomy for cancer: a systematic review and meta-analyses. Ann Surg Oncol 2022;29:1358–1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Mils K, Miró M, Farran L, et al. A pilot randomized controlled trial on the utility of gastric conditioning in the prevention of esophagogastric anastomotic leak after Ivor Lewis esophagectomy. The APIL_2013 Trial. Int J Surg 2022;106:106921. [DOI] [PubMed] [Google Scholar]
  • 14. Lai Y, Zeng X, Zhou K, et al. End to end intussusception anastomosis decreases the risk of anastomotic leakage after neoadjvant chemoradiation and McKeown oesophagectomy. Radiother Oncol 2021;158:285–292. [DOI] [PubMed] [Google Scholar]
  • 15. Weijs TJ, Berkelmans GH, Nieuwenhuijzen GA, et al. Routes for early enteral nutrition after esophagectomy. A systematic review. Clin Nutr 2015;34:1–6. [DOI] [PubMed] [Google Scholar]
  • 16. Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165. [DOI] [PubMed] [Google Scholar]
  • 17. Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 2015;262:286–294. [DOI] [PubMed] [Google Scholar]
  • 18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kuhn K, Pasch S, Wojciechowski W, et al. Combined sleeve lobectomy and Ivor lLwis esophagectomy for synchronous primary carcinoma of the lung and Barrett esophagus. J Thorac Cardiovasc Surg 2000;119:1289–1290. [DOI] [PubMed] [Google Scholar]
  • 20. Ishii H, Sato H, Tsubosa Y, et al. Treatment of double carcinoma of the esophagus and lung. Gen Thorac Cardiovasc Surg 2008;56:126–130. [DOI] [PubMed] [Google Scholar]
  • 21. Bootsma BT, Huisman DE, Plat VD, et al. Towards optimal intraoperative conditions in esophageal surgery: a review of literature for the prevention of esophageal anastomotic leakage. Int J Surg 2018;54(Pt A):113–123. [DOI] [PubMed] [Google Scholar]
  • 22. Michelet P, D’Journo XB, Roch A, et al. Perioperative risk factors for anastomotic leakage after esophagectomy: influence of thoracic epidural analgesia. Chest 2005;128:3461–3466. [DOI] [PubMed] [Google Scholar]
  • 23. van Rossum PSN, Haverkamp L, Verkooijen HM, et al. Calcification of arteries supplying the gastric tube: a new risk factor for anastomotic leakage after esophageal surgery. Radiology 2015;274:124–132. [DOI] [PubMed] [Google Scholar]
  • 24. Verstegen MHP, Bouwense SAW, van Workum F, et al. Management of intrathoracic and cervical anastomotic leakage after esophagectomy for esophageal cancer: a systematic review. World J Emerg Surg 2019;14:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Scheingraber S, Dobbert D, Schmiedel P, et al. Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery. Surg Today 2005;35:846–854. [DOI] [PubMed] [Google Scholar]
  • 26. Sharma A, Deeb AP, Iannuzzi JC, et al. Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg 2013;258:296–300. [DOI] [PubMed] [Google Scholar]
  • 27. Briel JW, Tamhankar AP, Hagen JA, et al. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 2004;198:536–541. [DOI] [PubMed] [Google Scholar]
  • 28. Li SJ, Wang ZQ, Li YJ, et al. Diabetes mellitus and risk of anastomotic leakage after esophagectomy: a systematic review and meta-analysis. Dis Esophagus 2017;30:1–12. [DOI] [PubMed] [Google Scholar]
  • 29. Gronnier C, Tréchot B, Duhamel A, et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg 2014;260:764–770. [DOI] [PubMed] [Google Scholar]
  • 30. Merritt RE, Whyte RI, D’Arcy NT, et al. Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation. Ann Thorac Surg 2011;92:2034–2040. [DOI] [PubMed] [Google Scholar]
  • 31. Yoshimoto K, Nomori H, Mori T, et al. Postoperative change in pulmonary function of the ipsilateral preserved lung after segmentectomy versus lobectomy. Eur J Cardiothorac Surg 2010;37:36–39. [DOI] [PubMed] [Google Scholar]
  • 32. Wolf AS, Jacobson FL, Tilleman TR, et al. Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. Eur J Cardiothorac Surg 2010;37:770–775. [DOI] [PubMed] [Google Scholar]
  • 33. Hsia CC, Fryder-Doffey F, Stalder-Nayarro V, et al. Structural changes underlying compensatory increase of diffusing capacity after left pneumonectomy in adult dogs. J Clin Invest 1993;92:758–764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Slieker JC, Daams F, Mulder IM, et al. Systematic review of the technique of colorectal anastomosis. JAMA Surg 2013;148:190–201. [DOI] [PubMed] [Google Scholar]
  • 35. Markar S, Gronnier C, Duhamel A, et al. The impact of severe anastomotic leak on long-term survival and cancer recurrence after surgical resection for esophageal malignancy. Ann Surg 2015;262:972–980. [DOI] [PubMed] [Google Scholar]
  • 36. Fransen LFC, Verhoeven RHA, Janssen T, et al. The association between postoperative complications and long-term survival after esophagectomy: a multicenter cohort study. Dis Esophagus 2023;36:1–11. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SUPPLEMENTARY MATERIAL
js9-110-1653-s001.docx (31.2KB, docx)
Download video file (77.1MB, mp4)
js9-110-1653-s003.docx (139.2KB, docx)

Data Availability Statement

The data that support the findings of this study are available from the corresponding author and author initials, upon reasonable request.


Articles from International Journal of Surgery (London, England) are provided here courtesy of Wolters Kluwer Health

RESOURCES